Artwork

Contenu fourni par Jon Chee. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Jon Chee ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Player FM - Application Podcast
Mettez-vous hors ligne avec l'application Player FM !

🧬 David Li - Meliora Therapeutics - Part 1 | Childhood in China and Kentucky | Early Opportunities in Research & Biology | Benefits of Dual Degrees | Experiences & Opportunities while Investment Banking at Goldman Sachs

30:02
 
Partager
 

Manage episode 426659722 series 3461709
Contenu fourni par Jon Chee. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Jon Chee ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Part 1 of 4.

My guest for this week’s episode is David Li, CEO and co-founder of Meliora Therapeutics. Meliora's goal is to develop life-saving cancer therapies using cutting-edge science and machine learning. The company derives a comprehensive picture of how drugs interact with cancer biology by combining biofunctional readouts from numerous modalities using advanced machine learning and other computational techniques.

Before Meliora, David served as Chief Business Officer at Everest Detection, an early detection liquid biopsy startup, and was head of commercial operations at Benchling, a life sciences software platform company which has achieved a $6 billion valuation and has attracted over $500 million in funding from firms such as Altimeter Capital, Tiger Global, Lone Pine Capital, Benchmark, Sequoia, Excel, Lux, and numerous others. David began his career in Goldman Sachs Healthcare Investment Banking Group and KKR's Private Equity Group, where he advised and invested in transactions worth over $10 billion in enterprise value. David's multifaceted experiences in the financial and life science sectors give him a wide range of experiences that founders can learn from.

Join us this week and hear about:

  • David's childhood in China and Kentucky
  • Developing a passion for biology and chemistry at a young age
  • His experience in the University of Pennsylvania Life Sciences Management Program
  • His experience at Goldman Sachs, insights he's gained from Fortune 500 CEOs, his mentorship through Need You in New York City
  • His ongoing commitment to innovation and patient impact
  • And much more!

Please enjoy my conversation with David Li.

Timestamps
00:28 Intro
2:39 Episode starts, early years in China and Kentucky, developing a passion for biology and chemistry
9:58 Decision to attend the University of Pennsylvania and study biology and finance through the Roy Vagelos Life Science and Management Program
13:41 Experience and opportunities at Goldman Sachs as an investment banker
15:47 The role of investment banking, the integration of career paths with life sciences and biotech, and the value of analysis across fields
21:08 Balancing capital formation vs. innovation while keeping patient impact as the North Star of a company’s purpose
24:27 Insights gained from exposure to Fortune 500 or Fortune 100 CEOs and the impact of mentorships while at Goldman
27:44 David’s experience as a mentor through the New York Needs You program
29:01 Outro

Long-Form Video Timestamps:

00:00 Intro
2:10 Episode starts, early years in China and Kentucky, developing a passion for biology and chemistry
11:34 Decision to attend the University of Pennsylvania and study biology and finance through the Roy Vagelos Life Science and Management Program
16:16 Experience and opportunities at Goldman Sachs as an investment banker
18:52 The role of investment banking, the integration of career paths with life sciences and biotech, and the value of analysis across fields
25:26 Balancing capital formation vs. innovation while keeping patient impact as the North Star of a company’s purpose
30:03 Insights gained from exposure to Fortune 500 or Fortune 100 CEOs and the impact of mentorships while at Goldman
34:18 David’s experience as a mentor through the New York Needs You program
35:53 Outro

Find Our Guest, David Li, at these links:

Find Our Host, Jon Chee, at these links:

Social & Website
Enriched Notes:

Topics Mentioned:
Research in Biological Science at the University of Chicago Summer Program
University of Pennsylvania - Roy Vagelos Life Science and Management Program
Andrew Fire and Craig Mello - Nobel Prize Winners for RNA interference
Tide Pharma
Goldman Sachs
New York Needs You Program

Lab Equipment for Biochemistry Research
Strategies for Better Cash Flow Management
How do Core Labs Support Life Science Research?
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
  continue reading

76 episodes

Artwork
iconPartager
 
Manage episode 426659722 series 3461709
Contenu fourni par Jon Chee. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Jon Chee ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Part 1 of 4.

My guest for this week’s episode is David Li, CEO and co-founder of Meliora Therapeutics. Meliora's goal is to develop life-saving cancer therapies using cutting-edge science and machine learning. The company derives a comprehensive picture of how drugs interact with cancer biology by combining biofunctional readouts from numerous modalities using advanced machine learning and other computational techniques.

Before Meliora, David served as Chief Business Officer at Everest Detection, an early detection liquid biopsy startup, and was head of commercial operations at Benchling, a life sciences software platform company which has achieved a $6 billion valuation and has attracted over $500 million in funding from firms such as Altimeter Capital, Tiger Global, Lone Pine Capital, Benchmark, Sequoia, Excel, Lux, and numerous others. David began his career in Goldman Sachs Healthcare Investment Banking Group and KKR's Private Equity Group, where he advised and invested in transactions worth over $10 billion in enterprise value. David's multifaceted experiences in the financial and life science sectors give him a wide range of experiences that founders can learn from.

Join us this week and hear about:

  • David's childhood in China and Kentucky
  • Developing a passion for biology and chemistry at a young age
  • His experience in the University of Pennsylvania Life Sciences Management Program
  • His experience at Goldman Sachs, insights he's gained from Fortune 500 CEOs, his mentorship through Need You in New York City
  • His ongoing commitment to innovation and patient impact
  • And much more!

Please enjoy my conversation with David Li.

Timestamps
00:28 Intro
2:39 Episode starts, early years in China and Kentucky, developing a passion for biology and chemistry
9:58 Decision to attend the University of Pennsylvania and study biology and finance through the Roy Vagelos Life Science and Management Program
13:41 Experience and opportunities at Goldman Sachs as an investment banker
15:47 The role of investment banking, the integration of career paths with life sciences and biotech, and the value of analysis across fields
21:08 Balancing capital formation vs. innovation while keeping patient impact as the North Star of a company’s purpose
24:27 Insights gained from exposure to Fortune 500 or Fortune 100 CEOs and the impact of mentorships while at Goldman
27:44 David’s experience as a mentor through the New York Needs You program
29:01 Outro

Long-Form Video Timestamps:

00:00 Intro
2:10 Episode starts, early years in China and Kentucky, developing a passion for biology and chemistry
11:34 Decision to attend the University of Pennsylvania and study biology and finance through the Roy Vagelos Life Science and Management Program
16:16 Experience and opportunities at Goldman Sachs as an investment banker
18:52 The role of investment banking, the integration of career paths with life sciences and biotech, and the value of analysis across fields
25:26 Balancing capital formation vs. innovation while keeping patient impact as the North Star of a company’s purpose
30:03 Insights gained from exposure to Fortune 500 or Fortune 100 CEOs and the impact of mentorships while at Goldman
34:18 David’s experience as a mentor through the New York Needs You program
35:53 Outro

Find Our Guest, David Li, at these links:

Find Our Host, Jon Chee, at these links:

Social & Website
Enriched Notes:

Topics Mentioned:
Research in Biological Science at the University of Chicago Summer Program
University of Pennsylvania - Roy Vagelos Life Science and Management Program
Andrew Fire and Craig Mello - Nobel Prize Winners for RNA interference
Tide Pharma
Goldman Sachs
New York Needs You Program

Lab Equipment for Biochemistry Research
Strategies for Better Cash Flow Management
How do Core Labs Support Life Science Research?
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
  continue reading

76 episodes

Alle episoder

×
 
Loading …

Bienvenue sur Lecteur FM!

Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.

 

Guide de référence rapide